UNIVERSITY OF KENTUCKY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1865-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uky.edu
A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse
Not Applicable
Completed
- Conditions
- Sexual Violence
- Interventions
- Behavioral: Green DotBehavioral: Wellness Initiatives for Student Empowerment
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 427
- Registration Number
- NCT02591212
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Driving Neuroplasticity With Nerve Stimulation and Modified CIT
Phase 1
Completed
- Conditions
- StrokeCerebrovascular Accident
- Interventions
- Device: peripheral nerve stimulation
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 21
- Registration Number
- NCT02587234
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
Not Applicable
Completed
- Conditions
- Cocaine Use Disorder
- Interventions
- Behavioral: Active Inhibitory Control TrainingBehavioral: Neutral Inhibitory Control Training
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 40
- Registration Number
- NCT02444208
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Assessing and Addressing Behaviors in Children With Hearing Loss
Not Applicable
Completed
- Conditions
- Hearing LossParentingAttention Deficit and Disruptive Behavior Disorders
- Interventions
- Behavioral: Behavioral PlaceboBehavioral: Family Check Up Behavioral Parenting Training Program (BPT)
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 24
- Registration Number
- NCT02423746
- Locations
- 🇺🇸
Lexington Hearing and Speech Academy, Lexington, Kentucky, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States
🇺🇸Heuser Hearing Institute, Louisville, Kentucky, United States
Topiramate-Phentermine Combinations for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine Use Disorder
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 38
- Registration Number
- NCT02239913
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
n-Acetylcysteine and Cocaine
Early Phase 1
Completed
- Conditions
- Cocaine DependenceCocaine Abuse
- Interventions
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 15
- Registration Number
- NCT02141620
- Locations
- 🇺🇸
University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States
Reirradiation With Concurrent Paclitaxel for Breast Cancer
Phase 1
Withdrawn
- Conditions
- Breast Cancer
- Interventions
- Radiation: Paclitaxel+Initial Radiation+Boost
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- University of Kentucky
- Registration Number
- NCT02058667
- Locations
- 🇺🇸
Markey Cancer Center, Lexington, Kentucky, United States
Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery
Completed
- Conditions
- Post-operative Quadriceps InhibitionAdherence to Post-operative TreatmentPost-operative Lower Extremity FunctionPost-operative Quadriceps Weakness
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 87
- Registration Number
- NCT02058862
- Locations
- 🇺🇸
University of Kentucky Musculoskeletal Laboratory, Lexington, Kentucky, United States
🇺🇸University of Kentucky Orthopaedics and Sports Medicine Clinic, Lexington, Kentucky, United States
Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
Phase 1
Completed
- Conditions
- Lung CancerHead and Neck Cancer
- Interventions
- Drug: Low Intensity Counseling + Long Acting NRT + PRN NRTDrug: Low Intensity Counseling + vareniclineDrug: Low Intensity Counseling + bupropion + PRN NRTDrug: High Intensity Counseling + Long Acting NRT + PRN NRTDrug: High Intensity Counseling + bupropion + PRN NRTDrug: High Intensity Counseling + varenicline + PRN NRTDrug: High Intensity Counseling + Long Acting NRTDrug: High Intensity Counseling + bupropionDrug: High Intensity Counseling + vareniclineDrug: Low Intensity Counseling + varenicline + PRN NRTDrug: Low Intensity Counseling + Long Acting NRTDrug: Low Intensity Counseling + bupropion
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 93
- Registration Number
- NCT02048917
- Locations
- 🇺🇸
King's Daughters Medical Center, Ashland, Kentucky, United States
🇺🇸Hardin Memorial Health Cancer Care Center, Elizabethtown, Kentucky, United States
🇺🇸ARH Cancer Center, Hazard, Kentucky, United States
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
Early Phase 1
Completed
- Conditions
- Methamphetamine AbuseMethamphetamine Dependence
- Interventions
- First Posted Date
- 2013-10-22
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 24
- Registration Number
- NCT01967381
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States